MBK Partners related stories
All articles and analysis
Blackstone to invest $2bn alongside Korean pension fundEarlier this month, the pension fund struck similar deals with private equity firms, Oaktree Capital and MBK Partners.
- Credit woes hit Asia
Three large deals that have recently fallen apart show private equity activity in Asia is not immune to the global financial crisis, writes Siddharth Poddar.
- PCCW cancels $2.5bn auction
MBK, Macquarie, TPG and Providence were reportedly bidding on the telcom company, which represents the second Asian deal to be scuppered in recent days.
- MBK to invest $2bn alongside Korean pension
Earlier this week the $165bn National Pension Service struck a $3bn deal with Oaktree Capital to pursue Korean investments.
- Report: Carlyle, MBK, Affinity line up for Korea Life stake
The three buyout firms are reportedly seeking to acquire a 10 percent stake in the Korean life insurance company that could value the enterprise at more than $7.5bn.
- Report: PE firms vie for $2.5bn Asian telecoms deal
TPG, MBK Partners, Providence and Macquarie are reportedly among the firms that have made it through the first round of bidding for the media and telecommunications assets of Hong Kong-listed PCCW. Apax, Bain and Carlyle may also be second-round bidders.
- MBK to invest in Japanese jewellery brand
MBK Partners is set to invest ¥7bn in Tasaki Shinju to help strengthen the company's domestic market position and expand its overseas operations. This will be the firm's second deal in Japan.
- Bids for PCCW subsidiary closed today
The Hong Kong-listed telecommunications group has received 'a number of proposals' for its sale of a minority interest in a subsidiary. Private equity firms including TPG are reported to have bid.
- LP PROFILE
LP PROFILE 2007-06-01 Staff Writer Head office Tel: +1 416 730 5359Ontario Teachers' Pension PlanFax: +1 416 730 7675Boardwww.otpp.com5650 Yonge St.TorontoOntarioM2M 4H5CanadaASSETS / FUNDS UNDER MANAGEMENTC$106 billionYEAR FIRST INVESTED IN PRIVATE EQUITY1991NUMBER OF PRIVATE EQU
- MBK’s proposed buyout of pharmaceutical company uncertain
The Asian private equity firm’s S$357 million bid for AsiaPharm faces opposition from minority shareholders.